Compare JBHT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBHT | SNN |
|---|---|---|
| Founded | 1961 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 14.0B |
| IPO Year | N/A | 1999 |
| Metric | JBHT | SNN |
|---|---|---|
| Price | $188.68 | $33.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 4 |
| Target Price | ★ $168.72 | $32.83 |
| AVG Volume (30 Days) | ★ 1.3M | 476.9K |
| Earning Date | 01-15-2026 | 03-02-2026 |
| Dividend Yield | 0.93% | ★ 2.19% |
| EPS Growth | 5.00 | ★ 59.91 |
| EPS | ★ 5.77 | 0.56 |
| Revenue | ★ $12,048,818,000.00 | $5,944,000,000.00 |
| Revenue This Year | $1.31 | $7.78 |
| Revenue Next Year | $3.88 | $5.13 |
| P/E Ratio | $32.63 | ★ $29.10 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | $122.79 | $23.69 |
| 52 Week High | $190.95 | $38.79 |
| Indicator | JBHT | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 75.79 | 48.01 |
| Support Level | $172.79 | $32.68 |
| Resistance Level | $190.95 | $33.56 |
| Average True Range (ATR) | 4.91 | 0.41 |
| MACD | 1.91 | 0.14 |
| Stochastic Oscillator | 92.38 | 78.51 |
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.